Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “New York”
Sponsor: BlueRock Therapeutics
Parkinsons Disease (PD)
United States, Australia, Canada
Sponsor: Boehringer Ingelheim
Advanced Solid Cancer · Metastatic Solid Cancer
United States, Japan, Spain
- Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic LeukemiaActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma
United States
- Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400Active Not Recruiting
Sponsor: AbbVie
Hepatocellular Carcinoma · Pancreatic Ductal Adenocarcinoma · Biliary Tract Cancers · Esophageal Squamous Cell Carcinoma
United States, Australia, Israel, Japan, Puerto Rico +3 more
Sponsor: National Cancer Institute (NCI)
Recurrent Endometrial Carcinoma · Recurrent Fallopian Tube Carcinoma · Recurrent Ovarian Carcinoma · Recurrent Primary Peritoneal Carcinoma
United States, Puerto Rico
- Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder CancerActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Bladder Urothelial Carcinoma · Muscle Invasive Bladder Carcinoma · Stage II Bladder Cancer AJCC v8 · Stage IIIA Bladder Cancer AJCC v8
United States
- Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE StudyActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Clear Cell Renal Cell Carcinoma · Metastatic Malignant Neoplasm in the Bone · Metastatic Malignant Neoplasm in the Lymph Nodes · Metastatic Malignant Neoplasm in the Soft Tissue
United States, Puerto Rico
Sponsor: Procyrion
Heart Failure · Cardiorenal Syndrome · Cardio-Renal Syndrome · ADHF
United States, Hungary
- Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung CancerActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Metastatic Lung Non-Squamous Non-Small Cell Carcinoma · Recurrent Lung Non-Squamous Non-Small Cell Carcinoma · Stage IV Lung Cancer AJCC v8
United States
Sponsor: Kardigan, Inc.
Symptomatic Genetic Dilated Cardiomyopathy
United States, Belgium, Denmark, France, Hungary +6 more
Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland
Acute Myeloid Leukemia, Adult
United States, Australia, Austria, Belgium, Denmark +13 more
- Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch RepairActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Colon Adenocarcinoma · DNA Repair Disorder · Lynch Syndrome · Stage III Colon Cancer AJCC v8
United States, Germany, Puerto Rico
Sponsor: Eidos Therapeutics, a BridgeBio company
Amyloidosis · Amyloid Cardiomyopathy · Transthyretin Amyloidosis · Cardiomyopathies
United States, Argentina, Australia, Belgium, Brazil +19 more
- Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)Active Not Recruiting
Sponsor: National Cancer Institute (NCI)
Limited Stage Lung Small Cell Carcinoma · Stage I Lung Cancer AJCC v8 · Stage II Lung Cancer AJCC v8 · Stage III Lung Cancer AJCC v8
United States, Japan
- Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin LymphomaActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Ann Arbor Stage III Hodgkin Lymphoma · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Ann Arbor Stage III Mixed Cellularity Classic Hodgkin Lymphoma · Ann Arbor Stage III Nodular Sclerosis Classic Hodgkin Lymphoma
United States, Canada, Puerto Rico
Sponsor: Genmab
Advanced Solid Tumors
United States, Spain
Sponsor: Hoffmann-La Roche
Moderately to Severely Active Crohns Disease
United States, Argentina, Australia, Austria, Belgium +21 more
- Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or MetastaticActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IV Breast Cancer AJCC v8 · Breast Adenocarcinoma · HER2/Neu Negative
United States, South Africa
- Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple MyelomaActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Light Chain Deposition Disease · Smoldering Multiple Myeloma
United States, Ireland, Puerto Rico
- Assessing the Ability of Combination Treatment With Venetoclax to Permit Time Limited Therapy in Chronic Lymphocytic LeukemiaActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma
United States, Israel
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Active Not Recruiting
Sponsor: National Cancer Institute (NCI)
Advanced Lymphoma · Advanced Malignant Solid Neoplasm · Bladder Carcinoma · Breast Carcinoma
United States, Guam, Puerto Rico
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast CancerActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Breast Ductal Carcinoma In Situ · Invasive Breast Carcinoma · Multicentric Breast Carcinoma · Multifocal Breast Carcinoma
United States, Canada, Colombia, France, Ireland +5 more
Sponsor: Genmab
Follicular Lymphoma (FL)
United States, Australia, Belgium, Brazil, Bulgaria +27 more
- Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial CancerActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Localized Renal Pelvis and Ureter Urothelial Carcinoma · Locally Advanced Bladder Urothelial Carcinoma · Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma · Locally Advanced Ureter Urothelial Carcinoma
United States, Guam
- Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell LymphomasActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Diffuse Large B-Cell Lymphoma · Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · Double-Expressor Lymphoma · EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
United States